Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
Hali
Wadhamini
Beijing Hospital of Traditional Chinese Medicine
Washirika
Beijing Shijitan Hospital
Beijing Friendship Hospital
Beijing Municipal Administration of Hospitals

Maneno muhimu

Kikemikali

Nausea and vomiting are the most common symptoms experienced by cancer patients after chemotherapy. Some patients have to endure such unpleasant symptoms even after using of antiemetic or anti-vomiting medications.The purpose of this study is to assess the therapeutic effects and safety of acupuncture for chemotherapy-induced nausea and vomiting on patients with malignancy

Tarehe

Imethibitishwa Mwisho: 01/31/2015
Iliyowasilishwa Kwanza: 02/14/2015
Uandikishaji uliokadiriwa Uliwasilishwa: 02/16/2015
Iliyotumwa Kwanza: 02/22/2015
Sasisho la Mwisho Liliwasilishwa: 02/16/2015
Sasisho la Mwisho Lilichapishwa: 02/22/2015
Tarehe halisi ya kuanza kwa masomo: 01/31/2015
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 11/30/2015
Tarehe ya Kukamilisha Utafiti: 11/30/2016

Hali au ugonjwa

Chemotherapy-induced Nausea and Vomiting

Uingiliaji / matibabu

Other: Verum acupuncture and medicine

Other: Sham acupuncture and medicine

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: Verum acupuncture and medicine
Participants will receive acupuncture therapy 1 hour prior to chemotherapy administration ,6 hours after chemotherapy administration,and once acupuncture therapy on the following day2,3,4,5. The stimulation points are RN12,LR13(bilaterally), RN6, ST25(bilaterally), PC6(bilaterally), ST36(bilaterally). The acupuncture needle in ST36 and auxiliary point will be connected to form a circuit containing a SDZ-V stimulator for 30 min with a frequency of 2/100 Hz.They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).
Other: Verum acupuncture and medicine
Participants will receive acupuncture therapy 1 hour prior to chemotherapy administration ,6 hours after chemotherapy administration,and once acupuncture therapy on the following day2,3,4,5. The stimulation points are RN12,LR13(bilaterally), RN6, ST25(bilaterally), PC6(bilaterally), ST36(bilaterally). The acupuncture needle in ST36 and auxiliary point will be connected to form a circuit containing a SDZ-V stimulator for 30 min with a frequency of 2/100 Hz. They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).
Sham Comparator: Sham acupuncture and medicine
Participants will receive minimal acupuncture therapy at the same time as the intervention group .The stimulation points are not belong to traditional Chinese medicine.They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).
Other: Sham acupuncture and medicine
Participants will receive minimal acupuncture therapy at the same time as the intervention group .The stimulation points are not belong to traditional Chinese medicine.They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

1. Patients with definite pathological diagnosis of lung cancer, breast cancer, and gynecological cancer.They haven't receive any chemotherapy or radiotherapy treatment for three months prior to join this study.

2. Aged 18-75.

3. Patients will receive chemotherapy treatment which included Cisplatin, anthracycline or taxane during the study period.

4. ECOG score is between 0 and 2.

5. The patients are diagnosed with insufficiency of spleen-qi and stomach-qi,reverse ascending of Stomach-Qi in traditional Chinese medicine theory.

6. The expected lifetime of the patient is longer than 6 months.

7. Patients willing to participate in the study and sign the consent form.

Exclusion Criteria:

1. Patients have serious disease in cardiovascular system ,liver system,kidney system, immune systems and hemopoietic system.

2. Pregnant and lactating women.

3. Patients have intractable vomiting caused by malignant brain metastases, intracranial hypertention, digestive tract obstruction, severe liver or Renal dysfunction, brain tumors, cerebrovascular disease, or other reasons.

4. Patients with Coagulopathy, thrombocytopenia, or suffering from bleeding disorders.

5. Patients have been definitely diagnosed with depression, anxiety disorders and psychosis

6. Patients with Sepsis or Bacteremia.

7. Patients have lymphedema in acupuncture stimulation area.

8. Patients who are afraid of acupuncture stimulation or allergic to stainless steel needles can't participate in this study.

Matokeo

Hatua za Matokeo ya Msingi

1. Change from Baseline in severity of nausea and vomiting at 21 days [It will be assessed at baseline,day1, day 2, day 3, day 7(±1),day 10(±1), day 14(±1), day 21(±1).Patients have a daily questionnaire about nausea and vomiting during chemotherapy to record their feelings]

The severity of nausea and vomiting will be assessed by the Common Terminology Criteria for Adverse Events (CTCAE)

Hatua za Matokeo ya Sekondari

1. TCM symptoms scale [It will be assessed at baseline, day3, day7(±1), day14(±1), day21(±1).Patients will be accessed with questionaire by doctors.]

to evaluate TCM syndrome

2. ECOG score scale [It will be assessed at baseline, day3, day7(±1), day14(±1), day21(±1).Patients will be accessed with questionaire by doctors.]

to evaluate physical condition of patients

3. HADS [It will be assessed at baseline, day3, day7(±1), day14(±1), day21(±1).Patients will be accessed with questionaire by doctors.]

a questionnaire to access the anxiety levels of patients

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge